A Case of Hypogonadotropic Hypogonadism Caused by Opioid Treatment for Nonmalignant Chronic Pain
Author(s) -
Yukiko Tabuchi,
Tetsuyuki Yasuda,
Hideaki Kaneto,
Tetsuhiro Kitamura,
Junji Kozawa,
Michio Otsuki,
Akihisa Imagawa,
Aya Nakae,
Youichi Matsuda,
H Uematsu,
Takashi Mashimo,
Masahiko Shibata,
Iichiro Shimomura
Publication year - 2012
Publication title -
case reports in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.2
H-Index - 20
eISSN - 1687-9627
pISSN - 1687-9635
DOI - 10.1155/2012/740603
Subject(s) - hypogonadotropic hypogonadism , medicine , opioid , endocrine system , erectile dysfunction , chronic pain , magnetic resonance imaging , hormone , pediatrics , physical therapy , radiology , receptor
We report a case of 42-year-old male patient with hypogonadotropic hypogonadism. He suffered from general fatigue and erectile dysfunction after the treatment with transdermal fentanyl for chronic pain by traffic injury. Endocrine examinations and hormone stimulating tests showed that he had hypogonadotropic hypogonadism. Brain magnetic resonance imaging (MRI) showed no abnormal findings, and he had no past history of accounting for acquired hypogonadotropic hypogonadism. Therefore, his hypogonadism was diagnosed to be caused by opioid treatment. Although opioid-induced endocrine dysfunctions are not widely recognized, this case suggests that we should consider the possibility of endocrine dysfunctions in patients with opioid treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom